{"id":"https://openalex.org/W1570566792","doi":"https://doi.org/10.4049/jimmunol.152.6.3189","title":"Induction of circulating antagonists to IL-1 and TNF by IL-2 administration and their effects on IL-2 induced cytokine production in vitro.","display_name":"Induction of circulating antagonists to IL-1 and TNF by IL-2 administration and their effects on IL-2 induced cytokine production in vitro.","publication_year":1994,"publication_date":"1994-03-01","ids":{"openalex":"https://openalex.org/W1570566792","doi":"https://doi.org/10.4049/jimmunol.152.6.3189","mag":"1570566792","pmid":"https://pubmed.ncbi.nlm.nih.gov/8144913"},"language":"en","primary_location":{"id":"doi:10.4049/jimmunol.152.6.3189","doi":"https://doi.org/10.4049/jimmunol.152.6.3189","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.152.6.3189","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050626665","display_name":"Herbert Tilg","orcid":"https://orcid.org/0000-0002-4235-2579","observed_orcids":["https://orcid.org/0000-0002-4235-2579"]},"institutions":[{"id":"https://openalex.org/I121934306","display_name":"Tufts University","ror":"https://ror.org/05wvpxv85","country_code":"US","type":"education","lineage":["https://openalex.org/I121934306"]},{"id":"https://openalex.org/I1290900354","display_name":"Tufts Medical Center","ror":"https://ror.org/002hsbm82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1290900354"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H Tilg","raw_affiliation_strings":["Hematology-Oncology, New England Medical Center and Tufts University School of Medicine , Boston, MA 02111","Department of Medicine, New England Medical Center, Boston, MA 02111"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology-Oncology, New England Medical Center and Tufts University School of Medicine , Boston, MA 02111","institution_ids":["https://openalex.org/I121934306","https://openalex.org/I1290900354"]},{"raw_affiliation_string":"Department of Medicine, New England Medical Center, Boston, MA 02111","institution_ids":["https://openalex.org/I1290900354"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071644055","display_name":"Leland Shapiro","orcid":"https://orcid.org/0000-0002-1392-3475","observed_orcids":["https://orcid.org/0000-0002-1392-3475"]},"institutions":[{"id":"https://openalex.org/I121934306","display_name":"Tufts University","ror":"https://ror.org/05wvpxv85","country_code":"US","type":"education","lineage":["https://openalex.org/I121934306"]},{"id":"https://openalex.org/I1290900354","display_name":"Tufts Medical Center","ror":"https://ror.org/002hsbm82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1290900354"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L Shapiro","raw_affiliation_strings":["Geographic Medicine and Infectious Disease, Department of Medicine, New England Medical Center and Tufts University School of Medicine , Boston, MA 02111","Department of Medicine, New England Medical Center, Boston, MA 02111"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geographic Medicine and Infectious Disease, Department of Medicine, New England Medical Center and Tufts University School of Medicine , Boston, MA 02111","institution_ids":["https://openalex.org/I121934306","https://openalex.org/I1290900354"]},{"raw_affiliation_string":"Department of Medicine, New England Medical Center, Boston, MA 02111","institution_ids":["https://openalex.org/I1290900354"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070134622","display_name":"Edouard G. Vannier","orcid":"https://orcid.org/0000-0001-6654-9053","observed_orcids":["https://orcid.org/0000-0001-6654-9053"]},"institutions":[{"id":"https://openalex.org/I121934306","display_name":"Tufts University","ror":"https://ror.org/05wvpxv85","country_code":"US","type":"education","lineage":["https://openalex.org/I121934306"]},{"id":"https://openalex.org/I1290900354","display_name":"Tufts Medical Center","ror":"https://ror.org/002hsbm82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1290900354"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E Vannier","raw_affiliation_strings":["Geographic Medicine and Infectious Disease, Department of Medicine, New England Medical Center and Tufts University School of Medicine , Boston, MA 02111","Department of Medicine, New England Medical Center, Boston, MA 02111"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geographic Medicine and Infectious Disease, Department of Medicine, New England Medical Center and Tufts University School of Medicine , Boston, MA 02111","institution_ids":["https://openalex.org/I121934306","https://openalex.org/I1290900354"]},{"raw_affiliation_string":"Department of Medicine, New England Medical Center, Boston, MA 02111","institution_ids":["https://openalex.org/I1290900354"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029126023","display_name":"Debra D. Poutsiaka","orcid":"https://orcid.org/0000-0002-7867-393X","observed_orcids":["https://orcid.org/0000-0002-7867-393X"]},"institutions":[{"id":"https://openalex.org/I121934306","display_name":"Tufts University","ror":"https://ror.org/05wvpxv85","country_code":"US","type":"education","lineage":["https://openalex.org/I121934306"]},{"id":"https://openalex.org/I1290900354","display_name":"Tufts Medical Center","ror":"https://ror.org/002hsbm82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1290900354"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D D Poutsiaka","raw_affiliation_strings":["Geographic Medicine and Infectious Disease, Department of Medicine, New England Medical Center and Tufts University School of Medicine , Boston, MA 02111","Department of Medicine, New England Medical Center, Boston, MA 02111"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geographic Medicine and Infectious Disease, Department of Medicine, New England Medical Center and Tufts University School of Medicine , Boston, MA 02111","institution_ids":["https://openalex.org/I121934306","https://openalex.org/I1290900354"]},{"raw_affiliation_string":"Department of Medicine, New England Medical Center, Boston, MA 02111","institution_ids":["https://openalex.org/I1290900354"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065282550","display_name":"Elizabeth Trehu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I121934306","display_name":"Tufts University","ror":"https://ror.org/05wvpxv85","country_code":"US","type":"education","lineage":["https://openalex.org/I121934306"]},{"id":"https://openalex.org/I1290900354","display_name":"Tufts Medical Center","ror":"https://ror.org/002hsbm82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1290900354"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E Trehu","raw_affiliation_strings":["Hematology-Oncology, New England Medical Center and Tufts University School of Medicine , Boston, MA 02111","Department of Medicine, New England Medical Center, Boston, MA 02111"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology-Oncology, New England Medical Center and Tufts University School of Medicine , Boston, MA 02111","institution_ids":["https://openalex.org/I121934306","https://openalex.org/I1290900354"]},{"raw_affiliation_string":"Department of Medicine, New England Medical Center, Boston, MA 02111","institution_ids":["https://openalex.org/I1290900354"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052526230","display_name":"Michael B. Atkins","orcid":"https://orcid.org/0000-0003-3901-9924","observed_orcids":["https://orcid.org/0000-0003-3901-9924"]},"institutions":[{"id":"https://openalex.org/I121934306","display_name":"Tufts University","ror":"https://ror.org/05wvpxv85","country_code":"US","type":"education","lineage":["https://openalex.org/I121934306"]},{"id":"https://openalex.org/I1290900354","display_name":"Tufts Medical Center","ror":"https://ror.org/002hsbm82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1290900354"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M B Atkins","raw_affiliation_strings":["Hematology-Oncology, New England Medical Center and Tufts University School of Medicine , Boston, MA 02111","Department of Medicine, New England Medical Center, Boston, MA 02111"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology-Oncology, New England Medical Center and Tufts University School of Medicine , Boston, MA 02111","institution_ids":["https://openalex.org/I121934306","https://openalex.org/I1290900354"]},{"raw_affiliation_string":"Department of Medicine, New England Medical Center, Boston, MA 02111","institution_ids":["https://openalex.org/I1290900354"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028234430","display_name":"Charles Anthony Dinarello","orcid":"https://orcid.org/0000-0002-5073-8316","observed_orcids":["https://orcid.org/0000-0002-5073-8316"]},"institutions":[{"id":"https://openalex.org/I121934306","display_name":"Tufts University","ror":"https://ror.org/05wvpxv85","country_code":"US","type":"education","lineage":["https://openalex.org/I121934306"]},{"id":"https://openalex.org/I1290900354","display_name":"Tufts Medical Center","ror":"https://ror.org/002hsbm82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1290900354"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C A Dinarello","raw_affiliation_strings":["Geographic Medicine and Infectious Disease, Department of Medicine, New England Medical Center and Tufts University School of Medicine , Boston, MA 02111","Department of Medicine, New England Medical Center, Boston, MA 02111"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geographic Medicine and Infectious Disease, Department of Medicine, New England Medical Center and Tufts University School of Medicine , Boston, MA 02111","institution_ids":["https://openalex.org/I121934306","https://openalex.org/I1290900354"]},{"raw_affiliation_string":"Department of Medicine, New England Medical Center, Boston, MA 02111","institution_ids":["https://openalex.org/I1290900354"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068872933","display_name":"J W Mier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I121934306","display_name":"Tufts University","ror":"https://ror.org/05wvpxv85","country_code":"US","type":"education","lineage":["https://openalex.org/I121934306"]},{"id":"https://openalex.org/I1290900354","display_name":"Tufts Medical Center","ror":"https://ror.org/002hsbm82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1290900354"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J W Mier","raw_affiliation_strings":["Hematology-Oncology, New England Medical Center and Tufts University School of Medicine , Boston, MA 02111","Department of Medicine, New England Medical Center, Boston, MA 02111"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology-Oncology, New England Medical Center and Tufts University School of Medicine , Boston, MA 02111","institution_ids":["https://openalex.org/I121934306","https://openalex.org/I1290900354"]},{"raw_affiliation_string":"Department of Medicine, New England Medical Center, Boston, MA 02111","institution_ids":["https://openalex.org/I1290900354"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":1.6541,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.85758975,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"152","issue":"6","first_page":"3189","last_page":"3198"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.7759000062942505,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.7759000062942505,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.057999998331069946,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10371","display_name":"Immune Response and Inflammation","score":0.053199999034404755,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interleukin-2-therapy","display_name":"interleukin-2 therapy","score":0.9509999752044678},{"id":"https://openalex.org/keywords/interleukin-1-receptor-antagonist","display_name":"interleukin-1 receptor antagonist","score":0.9660000205039978},{"id":"https://openalex.org/keywords/soluble-tnf-receptor-p55","display_name":"soluble TNF receptor p55","score":0.9229999780654907},{"id":"https://openalex.org/keywords/interleukin-1beta","display_name":"IL-1\u03b2","score":0.6119999885559082},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.996999979019165},{"id":"https://openalex.org/keywords/proinflammatory-cytokine-production","display_name":"proinflammatory cytokine production","score":0.6990000009536743},{"id":"https://openalex.org/keywords/peripheral-blood-mononuclear-cells","display_name":"peripheral blood mononuclear cells","score":0.8679999709129333},{"id":"https://openalex.org/keywords/cytokine-antagonists","display_name":"cytokine antagonists","score":0.7139999866485596},{"id":"https://openalex.org/keywords/cytokine-downregulation","display_name":"cytokine downregulation","score":0.5529999732971191}],"concepts":[{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.6638537049293518},{"id":"https://openalex.org/C149892131","wikidata":"https://www.wikidata.org/wiki/Q14914156","display_name":"Interleukin 1 receptor antagonist","level":5,"score":0.6537834405899048},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.6102835536003113},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.603797435760498},{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.6027849912643433},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.5952728986740112},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.47407427430152893},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4425586462020874},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4258125126361847},{"id":"https://openalex.org/C16613235","wikidata":"https://www.wikidata.org/wiki/Q285982","display_name":"Endogeny","level":2,"score":0.41900312900543213},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.404421329498291},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.39529648423194885},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.38322150707244873},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3734959363937378},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3514291048049927},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3405177593231201},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.3352792263031006},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2225007712841034},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.2158476710319519},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0791638195514679}],"mesh":[{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007375","descriptor_name":"Interleukin-1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007963","descriptor_name":"Leukocytes, Mononuclear","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012795","descriptor_name":"Sialoglycoproteins","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D053590","descriptor_name":"Interleukin 1 Receptor Antagonist Protein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4049/jimmunol.152.6.3189","doi":"https://doi.org/10.4049/jimmunol.152.6.3189","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.152.6.3189","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},{"id":"pmid:8144913","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8144913","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of immunology (Baltimore, Md. : 1950)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9907000064849854}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.46000000834465027}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1895758168","display_name":null,"funder_award_id":"AI-07329","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G3352633964","display_name":"Infectious Disease Training-Pathogenesis/Host Response","funder_award_id":"T32AI007329","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G508098258","display_name":null,"funder_award_id":"AI\u201115614","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G5840812218","display_name":"IMMUNOBIOLOGY OF LAK CELLS","funder_award_id":"5r01ca043950-11","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G5963656535","display_name":null,"funder_award_id":"CA-43950","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1601991492","https://openalex.org/W95884546","https://openalex.org/W2109099411","https://openalex.org/W2085792661","https://openalex.org/W2387025069","https://openalex.org/W1487984429","https://openalex.org/W1631971313","https://openalex.org/W2089093824","https://openalex.org/W2114465053","https://openalex.org/W2144165008"],"abstract_inverted_index":{"The":[0],"objectives":[1],"of":[2,17,36,60,90,167,199,212,226,241],"this":[3],"study":[4],"were":[5],"to":[6,32,49,53,123,142,231,237],"determine":[7,50],"whether":[8,24],"intensive":[9],"immunotherapy":[10,158],"with":[11],"IL-2":[12,72,85,124,143,157,232],"results":[13,221],"in":[14,28,105,140,153,164,188,196,229],"detectable":[15],"levels":[16,26,79,114],"circulating":[18],"IL-1":[19,42,62,75,168,203],"and":[20,23,44,112,128,170,177,214],"TNF":[21,56,213],"antagonists":[22],"the":[25,34,51,58,83,106,113,118,130,154,163,181,189,195,205,210,224,239],"achieved":[27,152,187],"vivo":[29],"are":[30],"sufficient":[31,236],"affect":[33],"generation":[35,59,211],"secondary":[37],"proinflammatory":[38,242],"cytokines":[39],"such":[40],"as":[41],"beta":[43,169],"TNF-alpha.":[45],"We":[46],"also":[47,103],"sought":[48],"extent":[52],"which":[54],"endogenous":[55],"mediates":[57],"an":[61],"antagonist":[63,77],"by":[64,172,175],"IL-2-activated":[65,147,173],"PBMCs.":[66,148],"In":[67],"patients":[68],"undergoing":[69],"high":[70],"dose":[71],"immunotherapy,":[73],"plasma":[74,107,155,190],"receptor":[76,99,183],"(IL-1ra)":[78],"rose":[80],"dramatically":[81],"after":[82,109],"first":[84],"injection,":[86],"reaching":[87],"a":[88],"plateau":[89],"11.03":[91],"+/-":[92],"0.92":[93],"ng/ml":[94],"within":[95],"4":[96],"h.":[97],"TNF-soluble":[98],"p55":[100],"(TNFsRp55)":[101],"was":[102,218],"detected":[104],"shortly":[108],"initiating":[110],"treatment,":[111],"progressively":[115],"increased":[116],"throughout":[117],"treatment":[119],"course.":[120],"PBMCs":[121,135,174],"exposed":[122],"expressed":[125],"IL-1ra":[126,131,149,216,227],"mRNA":[127],"secreted":[129],"protein,":[132],"but":[133],"neither":[134],"nor":[136],"neutrophils":[137],"shed":[138],"TNFsRp55":[139,184],"response":[141,230],"or":[144,202],"supernatants":[145],"from":[146],"at":[150,185],"concentrations":[151,186],"during":[156],"(approximately":[159],"10":[160],"ng/ml)":[161],"inhibited":[162],"vitro":[165,197],"production":[166,198,240],"TNF-alpha":[171],"65%":[176],"30%,":[178],"respectively.":[179],"Although":[180],"monomeric":[182],"had":[191],"no":[192],"effect":[193],"on":[194],"IL-1ra,":[200],"TNF-alpha,":[201],"beta,":[204],"bivalent":[206],"TNFsRp75-Fc":[207],"chimera":[208],"suppressed":[209],"IL-1.":[215],"synthesis":[217],"unaffected.":[219],"These":[220],"suggest":[222],"that":[223],"amount":[225],"generated":[228],"is":[233],"most":[234],"likely":[235],"down-modulate":[238],"cytokines.":[243]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}